Double-Blind Comparison of Bradilan (Tetranicotinoylfructose) Tablets and Hexopal (Inositol Nicotinate) Tablets in the Treatment of Intermittent Claudication
Restricted accessResearch articleFirst published online November, 1975
Double-Blind Comparison of Bradilan (Tetranicotinoylfructose) Tablets and Hexopal (Inositol Nicotinate) Tablets in the Treatment of Intermittent Claudication
A double-blind comparison of Bradilan (tetranicotinoylfructose) tablets 250 mg and Hexopal (inositol nicotinate) 500 mg tablets in the treatment of intermittent claudication in fifty patients showed that, using walking distance as the main parameter, Bradilan tablets were highly significantly more effective (p < 0.002).
Get full access to this article
View all access options for this article.
References
1.
AndrewsGJudgeTGWalkeyF (1973) The Action of Tetranicotinoylfructose in Peripheral Vascular Disease. Practitioner211, 83
2.
BergeTJohansenE (1958) Hexanicit in the Treatment of Arterial Insufficiency in the Lower Extremities. Svenska Laekartidningen48, 3453
3.
BorodaC (1975) A Clinical Study of Bradilan (Tetranicotinoylfructose) in Diabetic Patients with Peripheral Vascular Disease. Journal of International Medical Research3, 10
